Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions

Eric M. Reiman, Kewei Chen, Richard John Caselli, Gene E. Alexander, Daniel Bandy, Jennifer L. Adamson, Wendy Lee, Ashley Cannon, Elizabeth A. Stephan, Dietrich A. Stephan, Andreas Papassotiropoulos

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

We recently implicated a cluster of nine single nucleotide polymorphisms from seven cholesterol-related genes in the risk of Alzheimer's disease (AD) in a European cohort, and we proposed calculating an aggregate cholesterol-related genetic score (CREGS) to characterize a person's risk. In a separate study, we found that apolipoprotein E (APOE) e{open}4 gene dose, an established AD risk factor, was correlated with fluorodeoxyglucose (FDG) positron emission tomography (PET) measurements of hypometabolism in AD-affected brain regions in a cognitively normal American cohort, and we proposed using PET as a presymptomatic endophenotype to help assess putative modifiers of AD risk. Thus, the objective in the present study is to determine whether CREGS is related to PET measurements of hypometabolism in AD-affected brain regions. DNA and PET data from 141 cognitively normal late middle-aged APOE e{open}4 homozygotes, heterozygotes and noncarriers were analyzed to evaluate the relationship between CREGS and regional PET measurements. Cholesterol-related genetic risk scores were associated with hypometabolism in AD-affected brain regions, even when controlling for the effects of APOE e{open}4 gene dose. The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk.

Original languageEnglish (US)
Pages (from-to)1214-1221
Number of pages8
JournalNeuroImage
Volume40
Issue number3
DOIs
StatePublished - Apr 15 2008

Fingerprint

Alzheimer Disease
Cholesterol
Positron-Emission Tomography
Brain
Apolipoproteins E
Genes
Endophenotypes
Homozygote
Heterozygote
Neuroimaging
Single Nucleotide Polymorphism
DNA

Keywords

  • Alzheimer's disease
  • Cholesterol
  • Endophenotype
  • Genetics
  • Positron emission tomography

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

Reiman, E. M., Chen, K., Caselli, R. J., Alexander, G. E., Bandy, D., Adamson, J. L., ... Papassotiropoulos, A. (2008). Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. NeuroImage, 40(3), 1214-1221. https://doi.org/10.1016/j.neuroimage.2007.12.066

Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. / Reiman, Eric M.; Chen, Kewei; Caselli, Richard John; Alexander, Gene E.; Bandy, Daniel; Adamson, Jennifer L.; Lee, Wendy; Cannon, Ashley; Stephan, Elizabeth A.; Stephan, Dietrich A.; Papassotiropoulos, Andreas.

In: NeuroImage, Vol. 40, No. 3, 15.04.2008, p. 1214-1221.

Research output: Contribution to journalArticle

Reiman, EM, Chen, K, Caselli, RJ, Alexander, GE, Bandy, D, Adamson, JL, Lee, W, Cannon, A, Stephan, EA, Stephan, DA & Papassotiropoulos, A 2008, 'Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions', NeuroImage, vol. 40, no. 3, pp. 1214-1221. https://doi.org/10.1016/j.neuroimage.2007.12.066
Reiman, Eric M. ; Chen, Kewei ; Caselli, Richard John ; Alexander, Gene E. ; Bandy, Daniel ; Adamson, Jennifer L. ; Lee, Wendy ; Cannon, Ashley ; Stephan, Elizabeth A. ; Stephan, Dietrich A. ; Papassotiropoulos, Andreas. / Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. In: NeuroImage. 2008 ; Vol. 40, No. 3. pp. 1214-1221.
@article{a7bcc4ba4e4a457d9b089779f0757081,
title = "Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions",
abstract = "We recently implicated a cluster of nine single nucleotide polymorphisms from seven cholesterol-related genes in the risk of Alzheimer's disease (AD) in a European cohort, and we proposed calculating an aggregate cholesterol-related genetic score (CREGS) to characterize a person's risk. In a separate study, we found that apolipoprotein E (APOE) e{open}4 gene dose, an established AD risk factor, was correlated with fluorodeoxyglucose (FDG) positron emission tomography (PET) measurements of hypometabolism in AD-affected brain regions in a cognitively normal American cohort, and we proposed using PET as a presymptomatic endophenotype to help assess putative modifiers of AD risk. Thus, the objective in the present study is to determine whether CREGS is related to PET measurements of hypometabolism in AD-affected brain regions. DNA and PET data from 141 cognitively normal late middle-aged APOE e{open}4 homozygotes, heterozygotes and noncarriers were analyzed to evaluate the relationship between CREGS and regional PET measurements. Cholesterol-related genetic risk scores were associated with hypometabolism in AD-affected brain regions, even when controlling for the effects of APOE e{open}4 gene dose. The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk.",
keywords = "Alzheimer's disease, Cholesterol, Endophenotype, Genetics, Positron emission tomography",
author = "Reiman, {Eric M.} and Kewei Chen and Caselli, {Richard John} and Alexander, {Gene E.} and Daniel Bandy and Adamson, {Jennifer L.} and Wendy Lee and Ashley Cannon and Stephan, {Elizabeth A.} and Stephan, {Dietrich A.} and Andreas Papassotiropoulos",
year = "2008",
month = "4",
day = "15",
doi = "10.1016/j.neuroimage.2007.12.066",
language = "English (US)",
volume = "40",
pages = "1214--1221",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions

AU - Reiman, Eric M.

AU - Chen, Kewei

AU - Caselli, Richard John

AU - Alexander, Gene E.

AU - Bandy, Daniel

AU - Adamson, Jennifer L.

AU - Lee, Wendy

AU - Cannon, Ashley

AU - Stephan, Elizabeth A.

AU - Stephan, Dietrich A.

AU - Papassotiropoulos, Andreas

PY - 2008/4/15

Y1 - 2008/4/15

N2 - We recently implicated a cluster of nine single nucleotide polymorphisms from seven cholesterol-related genes in the risk of Alzheimer's disease (AD) in a European cohort, and we proposed calculating an aggregate cholesterol-related genetic score (CREGS) to characterize a person's risk. In a separate study, we found that apolipoprotein E (APOE) e{open}4 gene dose, an established AD risk factor, was correlated with fluorodeoxyglucose (FDG) positron emission tomography (PET) measurements of hypometabolism in AD-affected brain regions in a cognitively normal American cohort, and we proposed using PET as a presymptomatic endophenotype to help assess putative modifiers of AD risk. Thus, the objective in the present study is to determine whether CREGS is related to PET measurements of hypometabolism in AD-affected brain regions. DNA and PET data from 141 cognitively normal late middle-aged APOE e{open}4 homozygotes, heterozygotes and noncarriers were analyzed to evaluate the relationship between CREGS and regional PET measurements. Cholesterol-related genetic risk scores were associated with hypometabolism in AD-affected brain regions, even when controlling for the effects of APOE e{open}4 gene dose. The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk.

AB - We recently implicated a cluster of nine single nucleotide polymorphisms from seven cholesterol-related genes in the risk of Alzheimer's disease (AD) in a European cohort, and we proposed calculating an aggregate cholesterol-related genetic score (CREGS) to characterize a person's risk. In a separate study, we found that apolipoprotein E (APOE) e{open}4 gene dose, an established AD risk factor, was correlated with fluorodeoxyglucose (FDG) positron emission tomography (PET) measurements of hypometabolism in AD-affected brain regions in a cognitively normal American cohort, and we proposed using PET as a presymptomatic endophenotype to help assess putative modifiers of AD risk. Thus, the objective in the present study is to determine whether CREGS is related to PET measurements of hypometabolism in AD-affected brain regions. DNA and PET data from 141 cognitively normal late middle-aged APOE e{open}4 homozygotes, heterozygotes and noncarriers were analyzed to evaluate the relationship between CREGS and regional PET measurements. Cholesterol-related genetic risk scores were associated with hypometabolism in AD-affected brain regions, even when controlling for the effects of APOE e{open}4 gene dose. The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk.

KW - Alzheimer's disease

KW - Cholesterol

KW - Endophenotype

KW - Genetics

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=40849111266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40849111266&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2007.12.066

DO - 10.1016/j.neuroimage.2007.12.066

M3 - Article

C2 - 18280754

AN - SCOPUS:40849111266

VL - 40

SP - 1214

EP - 1221

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 3

ER -